文献速递甲状腺疾病

甲状腺功能对止血、凝血与纤溶影响的孟德尔随机化研究

Effects of Thyroid Function on Hemostasis, Coagulation, and Fibrinolysis: A Mendelian Randomization Study.
PubMed 文献 · Thyroid · 2021-08-05

该研究采用两样本孟德尔随机化方法,评估遗传预测的甲状腺功能状态对凝血与纤溶标志物的因果效应。结果显示遗传预测的TSH升高与VWF和纤维蛋白原降低相关,fT4升高与VWF升高相关,甲亢与VWF和FVIII升高相关。其他凝血与纤溶因子的关联尚不明确。

要点

  • 遗传预测TSH升高与VWF和纤维蛋白原降低相关。
  • 遗传预测fT4升高与VWF升高相关。
  • 遗传预测甲亢与VWF和FVIII升高相关。

核心结论

  • 遗传预测的TSH和fT4升高可能分别与VWF合成减少和增加相关。
  • 鉴于所分析特征间的相关性,Bonferroni校正可能过于保守,不能排除甲状腺特征与凝血或纤溶因子的名义关联。

研究设计与样本

  • 采用两样本孟德尔随机化研究,使用全基因组关联变异。
  • 评估遗传预测的甲减(N=134,641)、正常范围TSH(N=54,288)和fT4(N=49,269)、甲亢(N=51,823)及甲状腺过氧化物酶抗体阳性(N=25,821)对凝血与纤溶标志物的因果效应。
  • 凝血与纤溶数据来自CHARGE Hemostasis Consortium(N=2,583-120,246)。
  • 主要分析为逆方差加权随机效应模型,后续进行敏感性分析。

主要发现

  • 遗传预测TSH升高与VWF降低相关[β(SE)=-0.020(0.006),p=0.001]。
  • 遗传预测TSH升高与纤维蛋白原降低相关[β(SE)=-0.008(0.002),p=0.001]。
  • 遗传预测fT4升高与VWF升高相关[β(SE)=0.028(0.011),p=0.012]。
  • 遗传预测甲亢与VWF升高相关[β(SE)=0.012(0.004),p=0.006]及FVIII升高相关[β(SE)=0.013(0.005),p=0.007]。
  • 遗传预测甲减与TPA降低相关[β(SE)=-0.009(0.024),p=0.024],甲亢与TPA升高相关[β(SE)=0.022(0.008),p=0.008]。

关键数值与推荐

  • 双侧p<0.05为名义显著,p<0.0011[=0.05/(5暴露×9结局)]为Bonferroni显著。
  • MR敏感性分析显示方向相似但精度较低。
  • 其他凝血和纤溶因子的结果尚不明确。

临床怎么用

  • 提示甲状腺功能状态可能对VWF、纤维蛋白原、FVIII和TPA等止血标志物产生因果影响。
  • 在评估甲状腺疾病患者的凝血或纤溶风险时,可考虑上述标志物的潜在变化。

局限性

  • Bonferroni校正可能过于保守,因所分析特征间存在相关性。
  • MR敏感性分析精度较低。
  • 其他凝血和纤溶因子的关联结果尚不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Untreated hypothyroidism is associated with acquired von Willebrand syndrome, and hyperthyroidism is associated with increased thrombosis risk. However, the causal effects of thyroid function on hemostasis, coagulation, and fibrinolysis are unknown. Methods: In a two-sample Mendelian randomization (MR) study with genome-wide association variants, we assessed causality of genetically predicted hypothyroidism (N = 134,641), normal-range thyrotropin (TSH; N = 54,288) and free thyroxine (fT4) (N = 49,269), hyperthyroidism (N = 51,823), and thyroid peroxidase antibody positivity (N = 25,821) on coagulation (activated partial thromboplastin time, von Willebrand factor [VWF], factor VIII [FVIII], prothrombin time, factor VII, fibrinogen) and fibrinolysis (D-dimer, tissue plasminogen activator [TPA], plasminogen activator inhibitor-1) from the CHARGE Hemostasis Consortium (N = 2583-120,246). Inverse-variance-weighted random effects were the main MR analysis followed by sensitivity analyses. Two-sided p < 0.05 was nominally significant, and p < 0.0011[ = 0.05/(5 exposures × 9 outcomes)] was Bonferroni significant for the main MR analysis. Results: Genetically increased TSH was associated with decreased VWF [β(SE) = -0.020(0.006), p = 0.001] and with decreased fibrinogen [β(SE) = -0.008(0.002), p = 0.001]. Genetically increased fT4 was associated with increased VWF [β(SE) = 0.028(0.011), p = 0.012]. Genetically predicted hyperthyroidism was associated with increased VWF [β(SE) = 0.012(0.004), p = 0.006] and increased FVIII [β(SE) = 0.013(0.005), p = 0.007]. Genetically predicted hypothyroidism and hyperthyroidism were associated with decreased TPA [β(SE) = -0.009(0.024), p = 0.024] and increased TPA [β(SE) = 0.022(0.008), p = 0.008], respectively. MR sensitivity analyses showed similar direction but lower precision. Other coagulation and fibrinolytic factors were inconclusive. Conclusions: In the largest genetic studies currently available, genetically increased TSH and fT4 may be associated with decreased and increased synthesis of VWF, respectively. Since Bonferroni correction may be too conservative given the correlation between the analyzed traits, we cannot reject nominal associations of thyroid traits with coagulation or fibrinolytic factors.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Ellervik C, Mora S, Kuś A, et al. Effects of Thyroid Function on Hemostasis, Coagulation, and Fibrinolysis: A Mendelian Randomization Study. Thyroid. 2021. PMID: 34210154. doi:10.1089/thy.2021.0055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。